AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+8.57%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.2B
AUM Growth
+$642M
(+6.1%)
Cap. Flow
-$94.3M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97
Top Buys
| 1 |
Enterprise Products Partners
EPD
|
$60.6M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
$56.7M |
| 3 |
Cheniere Energy
CQP
|
$54.8M |
| 4 |
Western Midstream Partners
WES
|
$47.3M |
| 5 |
Albemarle
ALB
|
$27M |
Top Sells
| 1 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
$280M |
| 2 |
Hewlett Packard
HPE
|
$29.9M |
| 3 |
Exxon Mobil
XOM
|
$29M |
| 4 |
Lockheed Martin
LMT
|
$28.8M |
| 5 |
Valero Energy
VLO
|
$27.6M |
Sector Composition
| 1 | Energy | 63.96% |
| 2 | Technology | 5.43% |
| 3 | Healthcare | 4.22% |
| 4 | Consumer Discretionary | 3.76% |
| 5 | Financials | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Fulcrum Therapeutics
FULC
$414M
| $257K | ﹤0.01% |
+35,358
| New | +$257K |
|
952
Comerica
CMA
$8.85B
| $257K | ﹤0.01% |
3,843
-16
| -0.4% | -$1.07K |
|
953
Aura Biosciences
AURA
$403M
| $257K | ﹤0.01% |
+24,432
| New | +$257K |
|
|
FRC
954
DELISTED
First Republic Bank
FRC
| $256K | ﹤0.01% |
2,098
| – | – |
|
955
PDS Biotechnology
PDSB
$56.4M
| $256K | ﹤0.01% |
+19,367
| New | +$256K |
|
956
Weis Markets
WMK
$1.81B
| $255K | ﹤0.01% |
+3,099
| New | +$255K |
|
957
Horizon Bancorp
HBNC
$853M
| $255K | ﹤0.01% |
16,899
-109
| -0.6% | -$1.64K |
|
958
Kodiak Sciences
KOD
$556M
| $255K | ﹤0.01% |
35,546
+7,184
| +25% | +$51.4K |
|
959
LCI Industries
LCII
$2.57B
| $253K | ﹤0.01% |
2,741
| – | – |
|
960
West Pharmaceutical
WST
$18B
| $253K | ﹤0.01% |
1,075
-10
| -0.9% | -$2.35K |
|
961
Williams-Sonoma
WSM
$24.7B
| $252K | ﹤0.01% |
4,388
-24
| -0.5% | -$1.38K |
|
962
Range Resources
RRC
$8.27B
| $252K | ﹤0.01% |
10,074
| – | – |
|
963
AerSale
ASLE
$402M
| $250K | ﹤0.01% |
15,435
-71
| -0.5% | -$1.15K |
|
964
Western Alliance Bancorporation
WAL
$10B
| $250K | ﹤0.01% |
4,197
-26
| -0.6% | -$1.55K |
|
965
Allete
ALE
$3.69B
| $249K | ﹤0.01% |
+3,861
| New | +$249K |
|
966
Arbutus Biopharma
ABUS
$805M
| $248K | ﹤0.01% |
106,230
+24,352
| +30% | +$56.7K |
|
|
SBOW
967
DELISTED
SilverBow Resources, Inc.
SBOW
| $247K | ﹤0.01% |
8,748
| – | – |
|
968
Stoke Therapeutics
STOK
$1.13B
| $247K | ﹤0.01% |
26,749
+5,234
| +24% | +$48.3K |
|
969
Intercontinental Exchange
ICE
$99.8B
| $247K | ﹤0.01% |
2,403
| – | – |
|
970
SM Energy
SM
$3.09B
| $246K | ﹤0.01% |
7,075
| – | – |
|
971
Antero Resources
AR
$10.1B
| $246K | ﹤0.01% |
7,946
| – | – |
|
972
Equity Lifestyle Properties
ELS
$12B
| $246K | ﹤0.01% |
3,806
-1,225
| -24% | -$79.1K |
|
973
Carlisle Companies
CSL
$16.9B
| $246K | ﹤0.01% |
1,043
-6
| -0.6% | -$1.41K |
|
974
Ally Financial
ALLY
$12.7B
| $242K | ﹤0.01% |
9,906
| – | – |
|
975
CVR Partners
UAN
$930M
| $241K | ﹤0.01% |
2,392
-5
| -0.2% | -$503 |
|